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Angiopoietins are vascular factors essential for blood vessel assembly and correct organization andmaturation.This study describes
a novel calcium-dependent machinery activated through Angiopoietin-1/2-Tie receptor system in HUVECs monolayer. Both
cytokines were found to elicit intracellular calcium mobilization. Targeting intracellular Ca2+ signaling, antagonizing IP
3
with 2-
APB or cADPR with 8Br-cADPR, was found to modulate in vitro angiogenic responses to Angiopoietins in a specific way. 2-APB
and 8Br-cADPR impaired the phosphorylation of AKT and FAK induced by Ang-1 and Ang-2. On the other hand, phosphorylation
of ERK1/2 and p38, as well as cell proliferation, was not affected by either inhibitor. The ability of ECs to migrate following Angs
stimulation, evaluated by “scratch assay,” was reduced by either 2-APB or 8Br-cADPR following Ang-2 stimulation and only slightly
affected by 2-APB in cells stimulated with Ang-1. These results identify a novel calcium-dependent machinery involved in the
complex interplay regulating angiogenic processes showing that IP
3
- and cADPR-inducedCa2+ release specifically regulates distinct
Angs-mediated angiogenic steps.
1. Introduction
Angiogenesis is a complex remodeling process characterized
by the sprouting of new blood vessels from preexisting ones,
occurring mainly during embryonic development and in
pathological processes such as cancer. During the early stages
of this process, endothelial cells (ECs) are stimulated to form
new capillaries by growth factors such as vascular endothelial
growth factor (VEGF) and fibroblast growth factor (FGF).
Angiopoietins (Angs) play a fundamental role in the subse-
quent maturation step, in which microvessels acquire a layer
of mural cells, pericytes, and smooth muscle cells, which are
critical for the development and maintenance of functional
vasculature [1, 2]. Experimental evidence identifies the Angs
and their Tie receptors as important regulators of tumor-
induced angiogenesis and metastasis [3, 4]. So far, a major
effort in the field of angiogenesis control has centered on
the VEGF-VEGF receptor system [5, 6]. However, despite
partial success, resistance to anti-VEGF therapy, resulting
from a variety of mechanisms, remains a major obstacle [7–
9].The search for novel key downstreameffectors as a possible
common “signaling hub” between Angs and other known
growth factors is therefore of potential significance in the
perspective of angiogenesis control in cancer.
The Tie receptors and their Angiopoietin (Ang) ligands
have been identified as the second vascular tissue-specific
tyrosine kinase receptor system. Angs-Tie system is essen-
tial during embryonic vessel assembly and for the correct
organization and maturation of newly formed vessels and
functions as a key regulator of adult vascular homeostasis
in the later stages of the angiogenic cascade. Thus, whereas
VEGF signals promote initiating events in angiogenesis,
such as ECs sprouting and proliferation, Ang-Tie signals
appear to promote ECs survival and vascular assembly,
stability, and maturation [10]. The best-characterized Angs
are Angiopoietin-1 (Ang-1) and Angiopoietin-2 (Ang-2),
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which are secreted glycoproteins with a dimeric structure and
molecular weight of approximately 75 kDa [11] showing about
60% amino acid sequence homology. Ang-1 is expressed by
smooth muscle cells and other perivascular cells and acts
in a paracrine manner as agonist of the endothelial Tie-
2 receptor, whereas Ang-2 is considered as its antagonist
although also reported to context-dependently act as a Tie-
2 agonist inducing receptor phosphorylation [12–14]. The
molecular basis for agonistic versus antagonistic functions
of Ang-2 has not been unraveled. Cell type specific effects,
the degree of endothelial confluence, the duration of Ang-2
stimulation, concentration dependent effects, and the pres-
ence of the coreceptors such as Tie-1 have all been implicated
in controlling agonistic versus antagonistic function of Ang-
2 [15–18]. Ang-1 induces tyrosine phosphorylation of Tie-2
in ECs and activates downstream signaling pathways such as
mitogen-activated protein kinase (MAPK) pathways. In adult
tissues, Ang-1 does not induce endothelial chemotaxis or
proliferation but exerts a dual role: it stimulates angiogenesis
at sites of vascular remodeling contributing to the formation
of capillary sprouts, while it stimulates prosurvival pathways
and promotes vascular quiescence in mature vessels, pre-
venting apoptosis and inflammation through the activation
of PI3K-AKT and MAPK/ERK signaling pathways [19–21].
Ang-2 is almost exclusively expressed by ECs where it is
stored in Weibel-Palade bodies (WPB) [22, 23]. Following
cytokine activation of the endothelium, Ang-2 is rapidly
released and acts in an autocrine manner on Tie-2 receptor
binding as homodimers or multimers. Under physiological
conditions, in the adult tissues Ang-2 is expressed in regions
of vascular remodelling, during vascularization of the retina
or during vessel formation/regression of ovarian corpus
luteum. Ang-2 expression is also upregulated under patho-
logical conditions, for example, in the endothelium of tumors
[24–26]. Interestingly, experimental evidence indicates that
signaling downstream of Tie-2 activation is influenced by the
subcellular localization of the receptor, which is different in
confluent versus sparse ECs [1, 27]. In these studies, Ang-1
produced stronger AKT signaling in confluent cells, in which
Tie-2 was localized at cell/cell junctions, and stronger ERK
activation when cells were sparse and Tie-2 was localized at
cell/matrix junction, indicating that the effect of Ang-1 on
Tie-2 activation may depend on the nature of cell/cell or
cell/matrix contacts. Less well known is the role of calcium
(Ca2+) in the regulation of angiogenic processes. Ca2+ is
a crucial point of intersection for many distinct molecular
signaling pathways that promote and modulate angiogenesis.
Specific Ca2+ signatures rely upon spatiotemporal variations
in [Ca2+]i [28] and are mainly based on three second
messengers, namely, inositol trisphosphate (IP
3
) and cyclic
adenosine diphosphoribose (cADPR), which mobilize Ca2+
from endoplasmic reticulum (ER) stores, and nicotinic acid
adenine-dinucleotide phosphate (NAADP), which triggers
Ca2+ release from acidic organelles [29, 30]. We have pre-
viously demonstrated that histamine H1 receptors mediate
NAADP-dependent Ca2+ signaling in ECs [31] and have
recently identified that in HUVECs (human umbilical vein
endothelial cells) VEGF increases [Ca2+]i by mobilizing Ca
2+
from internal stores.The latter study demonstrated the direct
role of NAADP in VEGF-induced Ca2+ mobilization from
acidic organelles and its important involvement in the control
of angiogenic processes [32]. To our knowledge, the role
of Ca2+ signaling in the regulation of Ang-1/Ang-2-induced
angiogenesis has not been investigated yet. In the present
work, we identify a novel pathway for Angs-Tie signaling
whereby receptor activation leads to IP
3
- and cADPR-
dependent Ca2+ release and show that each of these Ca2+
mobilizing second messengers specifically controls distinct
Angs-mediated angiogenic steps.
2. Materials and Methods
2.1. Cell Culture. Human umbilical vein endothelial cells
(HUVECs) were obtained from Lonza Sales Ltd., cultured
in EGM-2 Endothelial Cell Growth Medium-2 (Endothelial
BasalMediumEBM-2 + EGM-2 Bullet Kit, Lonza), + 100mM
penicillin/streptomycin (Sigma). Cells were maintained at
37∘C in a humified 5% (vol/vol) incubator and grown to reach
the confluence. Monolayers were used at passages 1 to 6.
2.2. Calcium Imaging. Cells were incubated in EGM-2 con-
taining 3.5 𝜇M Fura-2-AM (Invitrogen) for 1 h at 37∘C and
then rinsed with Hanks’ Balanced Salt Solution (HBSS
Sigma) or Krebs-Henseleit-HEPES (KHH) buffer (140mM
Na+, 5.3mM K+, 132.4mM Cl−, 0.98mM PO
4
2−, 1.25mM
Ca2+, 0.81mM Mg2+, 5.5mM glucose, and 20mM HEPES).
Plates were placed into a culture chamber kept at 37∘C
controlled temperature on the stage of an inverted microflu-
orimeter (Nikon TE2000E) connected to a cooled CCD
camera (512BCascade, Princeton Instruments). Sampleswere
illuminated alternately at 340 and 380 nm using a random
access monochromator (Photon Technology International)
and emission was detected using a 510 nm emission filter.
Images were acquired (1 image/sec ratio) using MetaFluor
software (Universal Imaging Corporation). Calibration of the
signal was obtained at the end of each experiment by max-
imally increasing intracellular Ca2+-dependent Fura-2-AM
fluorescence with 5 𝜇M ionomycin (ionomycin calcium salt
from Streptomyces conglobatus, Sigma) followed by recording
minimal fluorescence in Ca2+-free medium. [Ca2+]i was
calculated according to previously described formulas [33].
2.3. Western Blot. Cells were first starved in EBM-2 for 4 h
and then incubated with BAPTA-AM (Sigma, 20𝜇M), 2-APB
(Sigma 75 𝜇M), or 8Br-cADPR (Sigma 30 𝜇M) for 30min
before stimulation for 20min with 100 ng/mL Angiopoietin-
1 or 200 ng/mL Angiopoietin-2 (PeproTech). Cells were
washed with cold PBS before adding lysis buffer 10X (Cell
Signaling), PI, and PMSF (Sigma 1mM). After determining
protein concentration by a BCA kit (Thermo Scientific),
25 𝜇g–35 𝜇g protein of each sample was loaded on 8%–10%
SDS-PAGE. The proteins were subsequently blotted onto a
nitrocellulose membrane and the membrane treated with a
blocking solution TTBS + 5% milk (ECL prime blocking
agent, GE Healthcare). The following primary antibodies
were used: Phospho-p42/44 MAPK (T202/Y204: E10, Cell
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Signaling, 1 : 1,000), Phospho-AKT (Ser-473, Cell Signaling,
1 : 1,000), Phospho-FAK (Tyr925, Cell Signaling, 1 : 1,000),
Phospho-p38 MAP Kinase (Thr180/Tyr182, Cell Signaling,
1 : 1,000), AKT (Cell Signaling, 1 : 1,000), ERK 2 (Santa Cruz,
1 : 1,000), p38 (Santa Cruz, 1 : 1,000), and FAK (Cell Signaling,
1 : 1,000). All the antibodies were diluted in TTBS 5% BSA.
After three washes in TTBS, the membrane was incubated
with a secondary HRP-conjugated stabilized goat anti-mouse
(Pierce, 1 : 10,000) and stabilized peroxidase-conjugated poly-
clonal goat anti-rabbit (Bio-Rad, 1 : 10,000) 1 h at RT. To
ensure equal loading membranes were reprobed with mono-
clonal HRP-conjugated anti-𝛽-actin (Sigma).The intensity of
Western blot bands was quantified by Image J software from
at least three independent experiments, normalized to both
total amount of the protein indicated and 𝛽-actin content,
and compared with control (vehicle) set as 1.
2.4. Scratch Assay. Confluent ECs monolayers plated in
35mm dishes were scraped along a straight line with a p10
pipette tip to create a narrow gap (scratch). The scratch
created was of similar size in the different experimental
conditions to minimize any possible variation caused by
differences in the width. Debris were removed by a wash
with PBS prior to incubation in fresh medium containing
Angs in the presence or absence of inhibitors. To record cell
migration, images of the wound were acquired at time zero
and again 24 h later in an invertedmicroscope (Nikon Eclipse
TS100) equipped with a digital camera (Nikon Ds Fi2, Nis
elements F 4.00.00 software). Five randommicroscopic fields
along each wound were photographed.
2.5. In Vitro Matrigel Assay. Capillary-like endothelial tube
formation was evaluated by an angiogenesis in vitro angio-
genesis assay. 130 𝜇L Matrigel basement membrane matrix
growth factor reduced (BD Biosciences) was added to each
well of precooled 24-well tissue culture plates. Pipette tips
and Matrigel solution were kept cold during the procedure
to avoid solidification. The plates were incubated for 1 h at
37∘C to allow matrix solution to solidify. 4 × 104 cells in a
final volume of 500 𝜇L EBM-2 were seeded onto the surface
of each well containing the polymerized matrix. Cells were
pretreated with the pharmacological inhibitors indicated or
with vehicle alone and stimulated with the specific agonists
100 ng/mL Ang-1 or 200 ng/mL Ang-2 for 4-5 hours at 37∘C.
Tube formation was inspected under an inverted microscope
(Nikon Eclipse TS100) at 20x magnification and images were
acquired by a digital camera (Nikon Ds Fi2, Nis elements F
4.00.00 software).The closed polygons formed in five random
microscopic fields per well were counted and values averaged.
2.6. Statistical Analysis. Data are presented as the mean ±
s.e.m. resulting from at least three independent experiments.
Student’s 𝑡-test was used for statistical comparison between
means where applicable. Consider ∗𝑃 < 0.05, ∗∗𝑃 < 0.01,
and ∗∗∗𝑃 < 0.001. Statistical analysis of the data in Figures
1(a) and 1(b) was performed using the one-way ANOVA test.
Consider ∗∗∗∗𝑃 value < 0.0001, ∗𝑃 value < 0.05. Bands on
Western blots were quantified by densitometric scanning of
films from three or more independent experiments.
3. Results and Discussion
3.1. Ang-1 and Ang-2 Mobilize Calcium from Intracellular
Calcium Stores. In the present study, the involvement of Ca2+
in the signaling of Angs was tested and analysed to inves-
tigate in ECs if Ca2+ is involved in responses to Angs. We
performed Ca2+ imaging experiments in HUVECs mono-
layer using microfluorimetric analysis. First, we performed
dose response experiments stimulating Fura-2-AM-loaded
HUVECs with Angs at different concentrations (5 ng/mL–
400 ng/mL) using HBSS buffer that allows Ca2+ entry from
the extracellular environment. The maximum increase in
intracellular Ca2+ concentration was found to take place at
the concentration of 100 ng/mL for Ang-1 and 200 ng/mL for
Ang-2 (Figures 1(a) and 1(b)).These two concentrations were
therefore used in all the subsequent experiments. In order
to investigate the involvement of extracellular Ca2+ influx,
we performed Ca2+ imaging experiments in Ang-1/Ang-2-
stimulated cells using Krebs-Henseleit-HEPES buffer (KHH)
and a Ca2+-free buffer containing the extracellular Ca2+
chelator EGTA (Figures 1(c1) and 1(d1)). Representative
[Ca2+]i profiles are shown in Figures 1(c2) and 1(d2). The
response to Angs was found to be buffer-independent, indi-
cating the involvement of intracellular stores. Taken together,
these data show for the first time that Angs stimulation
triggers intracellular Ca2+ signaling. The substantially equal
values observed in presence or absence of extracellular Ca2+
prompted us to evaluate the involvement of different intra-
cellular compartments in Angs-induced intracellular Ca2+
mobilization. We adopted a pharmacological approach using
bafilomycin A1, which inhibits pH-dependent Ca2+ uptake
into acidic stores by inhibition of the vacuolar-type H+-
ATPase pump, and thapsigargin, which inhibits ER SERCA
pumps [29]. Angs-induced Ca2+ release was significantly
impaired by thapsigargin (Figures 2(a) and 2(c)) but not by
bafilomycin A1 (Figures 2(b) and 2(d)), demonstrating that
Ca2+ stores different from acidic compartments are involved
in this process.
3.2. Both cADPR and IP3 Are Involved in [Ca2+]i Increase
Induced by Ang-1 and Ang-2. Many cell stimuli act on
receptors that are coupled to phospholipase C (PLC) that
hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP
2
) pro-
ducing IP
3
, in turn recognised by receptors located on the ER
resulting in the release of Ca2+. The spatially and temporally
organized pattern of Ca2+ release is a remarkably versatile
signaling system controlling amultitude of processes inmany
different cell types [34]. Another Ca2+ mobilizing messenger,
unrelated to IP
3
, has been identified as cyclic ADP-ribose
(cADPR) which activates the ryanodine receptors (RyRs)
in the sarco/ER [28]. To explore the involvement of these
two different second messengers responsible for Ang-1-
and Ang-2-dependent intracellular Ca2+ mobilization from
ER stores, a pharmacological approach was adopted using
inhibitors specifically targeting either of them at different
levels. The involvement of IP
3
was studied through Ca2+
imaging experiments in cells pretreated for 20min with 2𝜇M
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Figure 1: Continued.
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Figure 1: [Ca2+]i is increased by Ang-1 and Ang-2 stimulation. Live imaging in Fura-2-AM-loaded single cells. [Ca
2+
]i increases (nM)
following stimulation with either Ang-1 or Ang-2 at different concentrations (5 to 400 ng/mL) in Ca2+ containing HBSS buffer. Identification
of 100 ng/mL Ang-1 and 200 ng/mL Ang-2 as agonist concentrations is most effective in increasing [Ca2+]i levels (a, b). Data in bar charts
represent mean ± s.e.m. from three independent experiments. Statistical analysis of the data was performed using one-way ANOVA test.
∗∗∗∗
𝑃 value < 0.0001, ∗𝑃 value < 0.05. Lack of contribution from Ca2+ influx, tested in absence or presence of extracellular calcium (resp., in
KHH or HBSS buffer) (c, d). Changes in [Ca2+]i levels (nM) are shown as maximum concentration in bar charts (c1, d1) and as representative
traces (c2, d2) in cells stimulated with Ang-1 or Ang-2, at the respective maximal concentrations, or with vehicle alone. Agonist-stimulated
[Ca2+]i increases are substantially the same in the presence or absence of extracellular Ca
2+. Data in bar charts represent mean ± s.e.m. from
three independent experiments. Cell number = 78–155. ∗∗∗𝑃 < 0.001 versus vehicle by Student’s 𝑡-test. [Ca2+]i values in representative traces
are expressed as increase with respect to basal Ca2+ concentrations (Δ).
U73122, the antagonist of PLC, or U73343, its nonfunctional
analogue, and in cells pretreated for 30min with 75 𝜇M 2-
APB, the selective antagonist of IP
3
receptor, and stimulated
with 10 𝜇M ATP as positive control or Ang-1 or Ang-2.
Pretreatment with either inhibitor significantly impaired
Ang-1- and Ang-2-induced Ca2+ release (Figures 3(a3), 3(a5),
3(b3), and 3(b5)) and, as expected, blocked ATP-evoked Ca2+
mobilization, known to be dependent by IP
3
(Figures 3(a1)
and 3(b1)). Representative [Ca2+]i traces are shown in Figures
3(a2), 3(a4), 3(a6), 3(b2), 3(b4), and 3(b6).
To identify the possible involvement of cADPR, Ca2+
imaging experiments were performed on cells pretreated for
30min with 30 𝜇M8Br-cADPR, the cell permeant antagonist
of cADPR, that binds ER RyRs and then stimulated with
Ang-1 or Ang-2. As shown in Figure 4, intracellular Ca2+
release after stimulation with either Ang was significantly
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Figure 2: Ang-1 andAng-2mobilize [Ca2+]i fromER but not from acidic stores. Live imaging in Fura-2-AM-loaded single cells. Identification
of Ang-1- and Ang-2-activated [Ca2+]i stores. Histograms represent Ca
2+ release in cells stimulated with 100 ng/mL Ang-1 or 200 ng/mL Ang-
2 after pretreatment with vehicle alone, or with 1𝜇M thapsigargin for 15min (a, c), or with 500 nMbafilomycin A1 for 1 h in Ca2+-freemedium
KHH (b, d). Δ on the 𝑦-axes = nM. Data in bar charts represent mean ± s.e.m. from three independent experiments. Cell number = 68–187.
∗∗∗
𝑃 < 0.001 by Student’s 𝑡-test.
reduced in cells pretreated with this inhibitor (Figures
4(a1) and 4(a3)). Representative [Ca2+]i traces are shown
in Figures 4(a2) and 4(a4). These observations demonstrate
that Angs mobilize Ca2+ from ER stores through IP
3
and
cADPR signaling and that the involvement of either pathway
is Ang-1/2 isoform specific. In particular, the unexpected
partial insensitivity to thapsigargin, U73122, 2-APB, and 8Br-
cADPR, observed with Ang-2 stimulation, suggests that this
agonist might possibly rely upon additional Ca2+ storing
compartments/subcompartments [35].
3.3. Ang-1- and Ang-2-Dependent MAPK Pathways Are Dif-
ferently Regulated by IP3 and cADPR. Ang-1/Ang-2 signaling
via Tie-2 receptor is known to control specific essential steps
during angiogenesis, a process involving a complex network
of intracellular transduction pathways. The interaction of
Ang-1 with Tie-2 in the adult vascular system is essential for
ECs survival, migration, and vascular repair. It is known that
in ECs Ang-1 induces phosphorylation of AKT [36], ERK1/2
[27], and p38 mitogen-activated protein kinase (MAPKs)
[37]. Alitalo’s group [38] demonstrated that Ang-1 and Tie-2
form distinct signaling complexes depending on the presence
or absence of inter-ECs adhesion linked to the predominant
phosphorylation of AKT and weaker activation of ERK in
HUVECs monolayer. The intracellular phosphatidylinositol
3-kinase (PI3K)/AKT pathway is a key regulator of several
cellular processes and promotes cell survival in response to
various stresses such as nutrient deprivation. Among the
many signaling pathways that respond to stress, the members
of MAPK family are also essential for maintaining cell
viability. Several studies demonstrated that Ang-1 promotes
cell survival activating the MAPK and PI3K/AKT pathways
[16, 19]. During the early stages of angiogenesis, neovascular
sprouts are composed primarily by ECs. As they mature,
microvessels acquire a coating of mural cells, which are
critical for the development and maintenance of functional
vasculature. In a rat aorta model [39] p38 MAPK has been
shown to transduce signals critical for vascular remodeling
and maturation. With the aim of identifying the involvement
of Ca2+ in Angs-dependent signaling events, we evaluated the
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Figure 3: Ang-1- and Ang-2-dependent [Ca2+]i mobilization is inhibited by antagonists of PLC and of IP3R. Cells pretreated for 20min
with 2 𝜇M U73122 (antagonist of PLC) or U73343 (its nonfunctional analogue) and cells pretreated for 30min with 75 𝜇M 2-APB (selective
antagonist of IP
3
receptor) were stimulated with 10𝜇M ATP (positive control) or Angs in Ca2+-free medium KHH. Statistical evaluation of
Δ[Ca2+]i in response to each agonist in the presence or absence of the indicated inhibitors (a1, a3, a5, b1, b3, and b5). Changes in [Ca
2+
]i
levels are shown as representative traces indicating the effect of U73122/U73343 or 2-APB on cells stimulated with ATP or Ang-1 or Ang-2
in Ca2+-free medium (a2, a4, a6, b2, b4, and b6). Δ on the 𝑦-axes = nM. Data in bar charts represent mean ± s.e.m. from three independent
experiments. Cell number = 88–140. ∗∗∗𝑃 < 0.001 versus agonists by Student’s 𝑡-test. [Ca2+]i values in representative traces are expressed as
increase with respect to basal Ca2+ concentrations (Δ).
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Figure 4: RyR inhibition abates both Ang-1- and Ang-2-mediated intracellular calcium mobilization. Cells were pretreated for 30min with
30 𝜇M 8Br-cADPR (inactive analogue of cADPR) and then stimulated with Ang-1 or Ang-2 in Ca2+-free medium KHH. Histograms show
changes in [Ca2+]i levels in response to each agonist in the presence or absence of the indicated inhibitor (a1, a3). Representative traces showing
the effect of 8Br-cADPR on Ang-1-stimulated (a2) and Ang-2-stimulated (a4) cells. Δ on the 𝑦-axes = nM. Data in bar charts represent mean
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in representative traces are expressed as increase with respect to basal Ca2+ concentrations (Δ).
activation of their known protein targets ERK1/2, AKT, and
p38. HUVECs were pretreated or not with the Ca2+ chelator
BAPTA-AM at the concentration of 20𝜇M. As shown in
Figure 5(a) and Figures S1 A–F (in Supplementary Mate-
rial available online at http://dx.doi.org/10.1155/2015/965271),
both Angs activate the phosphorylation of AKT, ERK1/2,
and p38 and the combined treatment with BAPTA-AM
was found to inhibit both Ang-1- and Ang-2-dependent
AKT phosphorylation, while the phosphorylation of ERK1/2
was not affected. The lack of intracellular calcium had an
opposite effect on p38 phosphorylation. To further evaluate
the specific contribution of the different Ca2+ mobilizing
second messengers in AKT phosphorylation, we performed
Western blot analysis of cells with two specific inhibitors,
either 2-APB (for IP
3
/IP
3
R) or 8Br-cADPR (for cADPR/RyR)
prior to Angs stimulation. As shown in Figures 5(b) and
5(c) and Figures S1 G–L, the phosphorylation of AKT is
differentially regulated by the two Angs. Pretreatment with 2-
APB specifically reduced the extent of AKT phosphorylation
resulting from stimulationwithAng-1 suggesting the require-
ment of IP
3
-dependent Ca2+ release (Figures 5(b1) and 5(c1)),
while cADPR/RyR signaling is significantly not involved in
this response to either Ang-1 or Ang-2 (Figures 5(b2) and
5(c2)).
3.4. Different Ca2+ Signatures Regulate the Cell Migratory
Response to Ang-1 and Ang-2. During neovascularization
and angiogenesis ECs degrade the basement membrane and
migrate into the perivascular stroma in response to a gradient
of angiogenic factors. Cell migration and invasion of extra-
cellular matrix beneath the basement membrane are essential
steps involving reorganization of the actin cytoskeleton. The
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Figure 5: Calcium-dependent AKT and MAPK activation upon Ang-1/Ang-2 stimulation. Ang-1 and Ang-2 induce Ca2+-dependent AKT,
ERK1/2, and p38 phosphorylation. Confluent HUVECs were pretreated or not with 20 𝜇MBAPTA-AM for 1 h and stimulated with 100 ng/mL
Ang-1 or 200 ng/mL Ang-2 for 30min. Blots of total cell lysate were probed for the phosphorylation of downstream targets AKT, ERK1/2, and
p38. To ensure equal loading membranes were reprobed for the total amount of the indicated proteins and for 𝛽-actin. Representative blots
are shown from three to five independent experiments (a). Cells pretreated or not with 75𝜇M 2-APB or 30 𝜇M 8Br-cADPR and stimulated
with either Ang-1 or Ang-2. Blots of total cell lysate were probed for the phosphorylation of downstream target AKT. To ensure equal
loading membranes were reprobed for the total amount of the indicated protein and for 𝛽-actin. Representative blots are shown from three
independent experiments (b1, b2, c1, and c2).
focal adhesion kinase FAK, amember of nonreceptor tyrosine
kinases, plays a key role in regulating the dynamic changes in
actin cytoskeleton reorganization involved in migration and
adhesion. Ang-1 induces capillary sprouting activity through
nondirectional and directional migration mediated by Tie-2
but not Tie-1 receptor and induces tyrosine phosphorylation
of FAK which is dependent on PI3K activity [40–43]. To
identify the possible involvement of [Ca2+]i rise in Angs-
dependent activation of p-FAK, we performed Western blot
analysis in cells treated or not with the Ca2+ chelator BAPTA-
AM at the concentration of 20𝜇M prior to stimulation with
either Ang-1 or Ang-2. We observed that both Angs activate
p-FAK through a Ca2+-dependent mechanism (Figure 6(a),
Figures S2 A-B). To evaluate the contribution of the different
second messengers involved, cells were pretreated with two
specific inhibitors, 2-APB and 8Br-cADPR. FAK phosphory-
lation induced by Angs was found to depend on IP
3
signal
in cells stimulated with Ang-1 (Figures 6(b1) and 6(b2)) and
strongly by both second messengers in those stimulated with
Ang-2 (Figures 6(c1) and 6(c2), Figures S2 C–F). To further
test the specific involvement of IP
3
and cADPR in Ang-1- and
Ang-2-induced cell motility, we performed a “scratch assay”
in which confluent ECs monolayer is manually wounded
along a narrow line and subsequent cell migration to reform
the monolayer can be studied. The advantage of this method
is that cell migration can be monitored over time, thus
allowing us to estimate the rate of migratory response.
Quantification is arbitrary, depending on size of wound and
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Figure 6: 2-APB and 8Br-cADPR impair Angs-dependent cell migration on HUVECs. Ang-1 and Ang-2 induce Ca2+-dependent FAK
phosphorylation. Confluent HUVECs were pretreated or not with 20𝜇M BAPTA-AM for 1 h and stimulated with 100 ng/mL Ang-1 or
200 ng/mL Ang-2 for 30min. Blots of total cell lysate were probed for the phosphorylation of downstream target FAK. To ensure equal
loading membranes were reprobed for the total amount of the indicated protein and for 𝛽-actin (a). Cells pretreated or not with 75𝜇M 2-
APB or 30𝜇M 8Br-cADPR and stimulated with either Ang-1 or Ang-2 (b1, b2, c1, and c2). Representative blots are shown from three to five
independent experiments. Ang-1-induced EC migration is affected by treatment with the second messengers inhibitor 2-APB while Ang-2-
induced cell migration appears to be both IP
3
- and cADPR-dependent. Scratch assay to evaluate the cell migration capability in the indicated
experimental conditions. Wounded monolayers at the time of manual damage (𝑡 = 0 h upper panel) and after 24 h treatment (lower panel)
with Ang-1 (d), Ang-2 (e), and inhibitors as indicated. Pictures are representative of three independent experiments.
cell growth. In order to discriminate between migration and
proliferation, flow cytometric assessment of cell proliferation
with propidium iodide (PI) was performed (Figure S3). This
assay showed that, in the culture conditions of the wound
healing assay, ECs do not proliferate under Angs stimulation.
From a qualitative point of view, the wound healing assay
clearly demonstrated that the capability of ECs to move in
24 h under Ang-1 stimulation is modified by the treatment
with 2-APB, while under Ang-2 stimulation cell migration is
reduced by the treatment with either 8Br-cADPR or 2-APB
(Figures 6(d) and 6(e)).
3.5. Capillary-Like Network Formation Controlled by Ang-1
Is IP3-Dependent. The formation of capillary-like structures
in vivo is considered as representative of later, differentiative
stages of angiogenesis and is commonly assayed to test
the efficiency of compounds with pro- or antiangiogenic
functions. The Angs-Tie axis is essential for vasculogenesis,
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Figure 7: IP
3
pathway inhibition impairs Ang-1-induced capillary-like formation in vitro. Cells were plated in Matrigel-coated dishes and
incubated in EBM-2 + 2% FBS for 5 h in the presence or absence of Angs or/and inhibitors as indicated. Each condition was tested in triplicate.
Representative images of one of three independent experiments (Ang-1: a, b; Ang-2: d, e). Quantitative evaluation of tube formation as the
number of closed polygons formed in seven fields for each experimental condition (c, f). Data in bar charts represent mean ± s.e.m. of three
independent experiments. ∗𝑃 < 0.05 by Student’s 𝑡-test.
normal vascular development, and angiogenesis. When ECs
are plated onto a layer of gel matrix, they are stimulated to
migrate and differentiate into tubular-like structures simulat-
ing the in vivo process [44]. Matrigel, a complex compound
that mimics the extracellular matrix, containing extracellular
and basement membrane proteins, is known to be the most
potent matrix for tubule formation. This is usually assayed
in the presence of potential modulators of angiogenesis and
tubule development is observed over a 4 to 24 h period. Cord-
like capillary structures are visualized as close polygons and
the degree of complexity of the structure can be quantitatively
evaluated counting the number of close polygons or associ-
ating a score depending on the number of ECs composing
each of them. As shown in Figures 7(a) and 7(d), when
plated on Matrigel matrices at high densities, HUVECs form
cord-like capillary structures within a few hours, and this
process is enhanced by Ang-1 and Ang-2. To evaluate the
possible involvement of calcium signals in the regulation
of this angiogenic process, cells were pretreated with the
Ca2+ chelator BAPTA-AM at the concentration of 20𝜇M.
The formation of Angs-induced capillary-like structures was
impaired by this inhibitor in Ang-1 stimulated samples but
unaffected in cells stimulated with Ang-2, indicating that
this response to Ang-2 is [Ca2+]i-independent. To further
assess whether Ca2+ signal is dispensable for Ang-2 to induce
capillary-like formation, we performed the Matrigel assay in
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the presence of second messengers inhibitors as shown in
Figures 7(e) and 7(f) and found no evident inhibition of tube
formation. Moreover, to identify by which second messenger
Ang-1 controls the formation of capillary-like structures, cells
were pretreated with the same second messenger inhibitors.
Representative images show that this response to Ang-
1 was inhibited by 2-APB pretreatment (Figure 7(b)). An
approximate estimate of the efficiency of this process can be
inferred by the extent of cellular network formation, whereby
cells first align to form linear segments and subsequently
interconnect to form closed polygonal structures. As shown
in Figure 7(c), the number of closed polygons formed in
cells stimulated with Ang-1 in the presence of 2-APB is
significantly reduced compared with samples stimulated with
Ang-1 alone, indicating the involvement of IP
3
-mediated
Ca2+ signaling in capillary-like formation in vitro.
4. Conclusions
During the complex process of angiogenesis, a variety of
growth factors and cytokines are upregulated and exert their
functions through autocrine/paracrine signaling. Among
these, Ang-1 and Ang-2 play important roles. Ang-1 does
not stimulate ECs growth but rather promotes stabilization
of vascular network and branching morphogenesis in in
vitro and in vivo angiogenesis; conversely, Ang-2, a somehow
context-dependent antagonist of Ang-1, promotes vessels
destabilization favouring pericytes detachment [45]. In the
present study, we identified a novel Ca2+-dependent machin-
ery activated by Angs which controls angiogenic processes,
including migration and the ability to induce capillary-like
structures in vitro. Our data suggest that Ca2+ signalingmight
be envisaged as a possible “signaling hub” for Angs and
other angiogenic factors. Given the therapeutic potential of
angiogenesis-blocking therapies based on the inhibition of
specific signaling pathways, this concept could open the way
to novel experimental approaches in this field.
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